Search Stories

MIT researchers have developed a cryptographic system that could help neural networks identify promising drug candidates in massive pharmacological datasets while keeping the data private, which could enable broader pooling of sensitive pharmacological data for predictive drug discovery.

Cryptographic protocol enables greater collaboration in drug discovery

Neural network that securely finds potential drugs could encourage large-scale pooling of sensitive data.

October 18, 2018

MIT and MGH researchers have developed an automated deep-learning model, currently being used on real patients, that identifies dense breast tissue — a risk factor for breast cancer — in mammograms as reliably as expert radiologists.

Automated system identifies dense tissue, a risk factor for breast cancer, in mammograms

Deep-learning model has been used successfully on patients, may lead to more consistent screening procedures.

October 16, 2018

In this image of a growing mouse tumor, yellow fluorescence marks the presence of Lgr5+ cancer stem cells. Although Lgr5+ cells are only a minority of tumor cells, they are the source of all other tumor cells.

In pursuit of the elusive stem cell

New MIT initiative delves into the biology of stem cells and cancer stem cells, seeks ways to identify, purify, and propagate them.

October 15, 2018

MIT engineers have designed nanoparticles that can be attached to T cells and release T-cell-stimulating molecules called cytokines (yellow spheres). These cytokines activate T cells (blue) to attack nearby tumor cells.

Nanoparticles give immune cells a boost

Drugs carried in cellular “backpacks” help T cells to destroy tumors.

July 9, 2018

Great progress has been made in reducing the cancer death toll through better prevention and screening, according to a new article by MIT Professor Emerita Nancy Hopkins and colleagues.

3Q: Nancy Hopkins on the impact and potential of cancer prevention

Mechanism-based cancer prevention is poised to further decrease the numbers of U.S. cancer deaths, says MIT professor emerita.

June 25, 2018

Perioperative NSAIDs may prevent early metastatic relapse in post-surgical breast cancer patients

Mouse study links early metastasis to systemic inflammation caused by wound healing.

April 11, 2018

Anne Collin (left), a PhD student in the Department of Aeronautics and Astronautics, talks with Sruthi Davuluri, a Technology and Policy Program Master’s student, during the Women in Data Science conference student poster session.

Second annual Women in Data Science conference showcases research, explores challenges

Co-hosted by MIT's Institute for Data, Systems, and Society, WiDS Cambridge brings together students, academic leaders, and industry partners.

March 19, 2018

Five cancer researchers make up the MIT Center for Precision Cancer Medicine’s founding faculty. Left to right: Angela Koehler, Michael Hemann, Michael Yaffe (director), Forest White, and Matthew Vander Heiden.

Fine-tuning cancer medicine

New cancer research initiative eyes individualized treatment for patients.

February 1, 2018

MIT biologists have designed a new peptide that can disrupt a key protein that many types of cancers, including some forms of lymphoma, leukemia, and breast cancer, need to survive.

Biologists’ new peptide could fight many cancers

Drug that targets a key cancer protein could combat leukemia and other types of cancer.

January 15, 2018

Through a Bridge Project collaboration with David Weinstock (left) of the Dana-Farber Cancer Institute (DFCI), and MIT Professor Scott Manalis (center), cell-weighing technology is being evaluated in a clinical laboratory at DFCI. MIT visiting scientist Mark Stevens is pictured at right.

Over the river and do some good

The Bridge Project collaboration accelerates new, highly original, and powerful approaches to defeating cancer.

November 22, 2017

Researchers have developed a new method for making “blood biopsies” for cancer more effective by using whole exome sequencing to monitor tumor DNA from blood samples.

New techniques give blood biopsies greater promise

Improved methods validate the use of blood samples for studying patients’ cancer genomes.

November 6, 2017

More than 1,000 MIT alumni and friends celebrated the MIT Campaign for a Better World at the Boch Center Wang Theatre in downtown Boston on Sept. 28.

The Better World Tour comes home to Boston

Alumni and friends gather at the Boch Center Wang Theatre to celebrate the vibrant MIT community and the Institute's ambitious dreams for a better world.

October 20, 2017

A scanning electron micrograph of a human T lymphocyte (also called a T-cell) from the immune system of a healthy donor. Researchers have designed a synthetic gene circuit that triggers the immune system to attack cancers when it detects signs of the disease.

Gene circuit switches on inside cancer cells, triggers immune attack

Advance may open new pathways for cancer immunotherapy.

October 19, 2017

Pictured, left to right, are: Manisha Bahl, director of the Massachusetts General Hospital Breast Imaging Fellowship Program; MIT Professor Regina Barzilay (center); and Constance Lehman, professor at Harvard Medical School and chief of the Breast Imaging Division at MGH’s Department of Radiology.

Using artificial intelligence to improve early breast cancer detection

Model developed at MIT’s Computer Science and Artificial Intelligence Laboratory could reduce false positives and unnecessary surgeries.

October 16, 2017

Anantha Chandrakasan, dean of MIT’s School of Engineering, who negotiated the collaboration on behalf of MIT, speaks during the signing of the agreement with representatives of IBM.

3Q: Anantha Chandrakasan on new MIT–IBM Watson AI Lab

Lab seeks to expand the boundaries of research on artificial intelligence.

September 7, 2017

MIT News | Massachusetts Institute of Technology

Browse By

Topics

Departments

Centers, Labs, & Programs

Schools